The efficacy and safety of bivalirudin and heparin in patients with acute coronary syndrome: a systematic review and meta-analysis.

Syst Rev · 2025 · PMC11808951 · PMID 39930484

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Bivalirudin demonstrates certain advantages in reducing bleeding, which is a highly significant benefit for patients at high risk of bleeding.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.